SetPoint Medical Corporation announced that it will receive $30,607,151 in an equity round of funding on August 2, 2013. The round will see participation from seven investors. The securities will be issued pursuant to exemption provided under Regulation D.

As of August 8, 2013, the company announced that it has received $27,000,000 in its first tranche closing of the third round of funding from new investors Covidien Ventures, Boston Scientific Corporation, Action Potential Venture Capital Limited, a fund managed by GlaxoSmithKline plc, Investment Arm, and other existing investors Foundation Medical Partners, Morgenthaler, and Topspin Ventures.

On September 8, 2015, the company received $15,000,000 in its second tranche. The company has raised approximately $43,000,000 in funding so far in the transaction. As part of the round Juan-Pablo Mas of Action Potential Venture Capital joined the board of directors of the company.